Can Omicron's ‘immunity’ end Covid-19 pandemic? Experts hint at ‘silver lining’

Data from the past week suggest that a combination of widespread immunity and numerous mutations have resulted in a coronavirus that causes far less severe disease than previous iterations.
General view of the passenger check-in area as the coronavirus disease (Covid-19) pandemic continues at the international airport in Cancun, Mexico, on January 3, 2022. (Representational Image / REUTERS)
General view of the passenger check-in area as the coronavirus disease (Covid-19) pandemic continues at the international airport in Cancun, Mexico, on January 3, 2022. (Representational Image / REUTERS)
Updated on Jan 04, 2022 08:59 AM IST
Copy Link
Bloomberg |

A string of new studies has confirmed the silver lining of the omicron variant: Even as case numbers soar to records, the numbers of severe cases and hospitalizations have not. The data, some scientists say, signal a new, less worrying chapter of the pandemic.

“We’re now in a totally different phase,” said Monica Gandhi, an immunologist at the University of California, San Francisco. “The virus is always going to be with us, but my hope is this variant causes so much immunity that it will quell the pandemic.”

The omicron variant was discovered in South Africa just over a month ago, and experts caution that there is still plenty of time for the situation to change. But data from the past week suggest that a combination of widespread immunity and numerous mutations have resulted in a virus that causes far less severe disease than previous iterations.

One study out of South Africa found that patients admitted to the hospital there during the omicron-dominated fourth wave of the virus were 73% less likely to have the severe disease than patients admitted during the delta-dominated third wave. “The data is quite solid now that hospitalizations and cases are decoupled,” said Wendy Burgers, an immunologist at the University of Cape Town.

Early on, much of the alarm over omicron was due to the variant’s large number of mutations, many of which are on the spike protein, the part of the virus responsible for helping it invade host cells. Those mutations, early data suggested, allowed the virus to easily infect not only unvaccinated people but also to evade antibody responses from both previous infections and vaccines. But the question remained how omicron would fare once it made its way past those first lines of defense.

Several factors appear to have made the omicron variant less virulent, or severe, than previous waves of Covid-19. One factor is the virus’ ability to infect the lungs. Covid infections typically start in the nose and spread down the throat. A mild infection doesn’t make it much farther than the upper respiratory tract, but if the virus reaches the lungs, that’s usually when more severe symptoms occur.

But five separate studies in the past week suggested that the variant does not infect the lungs as easily as previous variants. In one study, released as an online pre-print by a large consortium of Japanese and American scientists, hamsters and mice infected with omicron experienced far less lung damage and were less likely to die than those infected with previous variants. Another study out of Belgium found similar outcomes in Syrian hamsters, which have been known to experience particularly severe illness with previous iterations of the virus.

In Hong Kong, scientists studied a small number of lung tissue samples from patients collected during surgery and found that omicron grew more slowly in those samples than other variants did. 

Burgers said this change in virulence likely has to do with how the virus’s anatomy changed.

“It used to use two different pathways to get into cells, and now because of all the changes to the spike protein, it’s preferring one of those pathways,” she said. “It seems to prefer to infect the upper respiratory tract rather than the lungs.”

This, Burgers said, could mean less severe infection, but also more transmissibility as the virus replicates more often in the upper respiratory tract, from which it can more easily spread.

While omicron may be good at evading the attacks of antibodies, recent studies have also shown that it has far less success avoiding the second-line defenses of vaccines and prior infections: T-cells and B-cells.

T-cells are responsible for attacking a virus once it makes its way into the body’s cells if antibodies fail to prevent infection in the first place. In a recent study by Burgers and colleagues, scientists used white blood cells from Covid patients to show that about 70-80% of the T-cell response is preserved compared with previous strains of the virus. That means that for those who are either vaccinated or had a Covid infection in the past 6 months, it is likely their T-cells can recognize omicron and fight it off relatively quickly. 

This latest research will need to be followed up with further study. If it holds up to additional scrutiny, it just might explain why current infections appear to be milder than in previous waves of the virus.

“When you start to see different kinds of data all pointing in the same direction, you begin to feel more confident that it’s going to hold up,” said Jessica Justman, a Columbia University Medical Center epidemiologist.

That said, as cases skyrocket, the absolute number of hospitalizations and deaths will still rise alongside them, even if those numbers tick up more slowly.

“When your denominator is very large because many, many people are getting infected, you still wind up having many people going to the hospital who need care,” Justman said.

Gandhi, at the University of California, San Francisco, said that while case numbers might be reaching records, she hopes omicron’s combination of high transmissibility and mild infection might signal the beginning of the end. She pointed to another study out last week from Hong Kong, which showed that vaccinated patients infected with omicron generated strong immune responses against other versions of the virus as well. This, she said, might explain why case numbers peaked quickly in South Africa.

“I hope this variant creates profound immunity in the population,” she said. “It will hopefully end the pandemic.”

Close Story

Less time to read?

Try Quickreads

  • A Member of the FBI search for evidence at the scene of a weekend shooting at a Tops supermarket in Buffalo, New York, on May 18, 2022. 

    New York: 911 dispatcher who took Buffalo shooting call put on leave

    A 911 dispatcher has been placed on leave and may lose her job after allegedly hanging up on an supermarket employee hiding during this weekend's shooting rampage in Buffalo, New York. “Termination will be sought” for the dispatcher at a disciplinary hearing later this month, said spokesperson for the executive of Erie County, Peter Anderson, in an email to The Associated Press on Wednesday. Anderson said it's unclear who hung up on whom.

  • An image from April of Sri Lanka Air Force members guarding the Prime Minister's official residence, Temple Trees, amid the country's economic crisis, in Colombo. (REUTERS)

    Sri Lanka economic crisis: CID interrogates 4 MPs over attacks on protesters

    A team of Sri Lanka's Criminal Investigations Department have questioned four Members of Parliament (MPs), including two former ministers, over last week's violence against protesters at two protest sites in Colombo, the country's largest city, local media has reported. According to reports, a CID team arrived at the Parliament Complex on Wednesday to interrogate--with the Speaker's permission--and record the statements of Rohitha Abeygunawardena and CB Ratnayake, both former ministers.

  • An image created during an investigation into an outbreak of monkeypox, which took place in the Democratic Republic of the Congo (DRC), 1996 to 1997, shows the hands of a patient with a rash due to monkeypox.

    US reports 1st monkeypox case of 2022: 10 things to know

    Though this is the first confirmed case in the United States, the US Centers for Disease Control and Prevention is preparing for the possibility of more monkeypox cases. Here are 10 things to know about monkeypox and the 1st case in the United States in 2022 1. The Massachusetts man travelled to Canada at the end of April to meet friends and returned in early May. This is the first case of monkeypox this year.

  • Members of the North Korean army supply medicines to residents at a pharmacy, amid growing fears over the spread of Covid-19, in Pyongyang, on May 18, 2022. 

    N.Korea ramping up production of drugs, medical supplies to fight Covid: Report

    North Korea is ramping up the production of drugs and medical supplies to combat the Covid-19 pandemic, which has wreaked havoc. According to the Korean Central News Agency on Thursday, North Korea is also increasing the production of traditional Korean medicines used to reduce fever and pain. In the capital city of Pyongyang and nearby regions, factories are churning out more injections, medicines and thermometers and other medical supplies.

  • Bridget Brink, nominated to be U.S. ambassador to Ukraine, testifies at her Senate Foreign Relations Committee confirmation hearing at the U.S. Capitol in Washington, U.S., May 10, 2022. REUTERS/Kevin Lamarque

    Biden nominee Bridget Brink set to be confirmed as new US envoy to Ukraine

    Veteran diplomat Bridget Brink, who was nominated by US President Joe Biden to be the country's next ambassador to war-hit Ukraine, was on Wednesday (local time) given a unanimous approval by the Senate Foreign Relations Committee for appointment to the post, which means that she just a step away from being Washington's new representative in the east European nation. She was nominated by Biden on April 25.

Story Saved
Saved Articles
My Reads
Sign out
New Delhi 0C
Thursday, May 19, 2022